• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Orthopedic Surgery

Very-low-calorie diets versus exercise alone for the treatement of hip osteoarthritis

byAdrian WongandThomas Su
August 4, 2025
in Orthopedic Surgery
Reading Time: 3 mins read
Shorter hospital stays after hip fracture linked to greater risk of short-term death
Share on FacebookShare on TwitterShare on LinkedIn

1. In this randomized controlled trial, a very-low-calorie diet plus exercise was not superior to exercise alone in reducing hip pain severity among patients with hip osteoarthritis and overweight or obesity.

2. However, very-low-calorie diet was associated with improvement in a number of secondary outcomes, including health-related quality of life, body weight, and BMI.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Weight loss is thought to be a potential treatment to reduce joint pain in osteoarthritis with overweight or obesity, but there have been concerns about generalizing promising findings from knee osteoarthritis to those with involvement of the hip. Studies have suggested that a very-low-calorie diet (VLCD) can lead to considerable weight loss, including among individuals with osteoarthritis. This study aimed to assess whether adding VLCD to standard exercise could improve hip pain severity compared with exercise alone in patients with hip osteoarthritis and overweight or obesity. At six months, both VLCD with exercise and exercise alone were associated with reduced hip pain severity, although no significant difference was seen between the groups. Similar results were seen at one year, as well as in subgroup analyses investigating the effects of sex, radiographic disease density, and treatment expectation on outcomes. However, VLCD was associated with greater improvements in quality of life, body mass index, and visceral and total body fat mass. Although more VLCD-plus-exercise participants reported adverse events, no serious adverse events were seen across both groups. The generalizability of this study is limited by lack of blinding, gender imbalance among participants, and a relatively short follow-up period. Nevertheless, this study suggests that, although the addition of a VLCD may not noticeably improve hip pain severity in the short term compared to exercise alone, it may be beneficial in the overall management of hip osteoarthritis.

Click to read this study in AIM

Relevant Reading: Comparing Video-Based, Telehealth-Delivered Exercise and Weight Loss Programs With Online Education on Outcomes of Knee Osteoarthritis: A Randomized Trial

RELATED REPORTS

In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks

Low-dose radiotherapy may be effective as a short-term therapeutic option in knee osteoarthritis

In-Depth [randomized controlled trial]: This randomized controlled trial aimed to assess whether VLCD plus exercise could reduce hip pain severity more than exercise alone among patients with hip osteoarthritis with overweight or obesity. A total of 101 participants were recruited from the community in Melbourne and Sydney, Australia. Inclusion criteria were age 50 years and older; hip pain for 3 or more months; hip pain of at least 4 on an 11-point numerical rating scale over the past week; radiographic evidence of osteoarthritis; and baseline body mass index (BMI) greater than 27 kg/m2. The primary outcome was 6-month change in hip pain severity, while secondary outcomes included BMI, physical function, hip-related quality of life, and visceral and total body fat mass at baseline and 6 months. No significant difference in hip pain severity was seen between the treatment and control groups at 6 months (mean, -0.6 units [95% CI, -1.5 to 0.3]; p = 0.20). In contrast, secondary outcomes at 6 months showed significant differences in favor of VLCD plus exercise for hip-related QoL (8.6 units [95% CI, 0.3 to 16.8]), health-related QoL (0.06 units [95% CI, 0.01 to 0.12]), body weight (-8.8 kg [95% CI, -11.1 to -6.4 kg]), BMI (-3.2 kg/m2 [95% CI, -4.0 to -2.3 kg/m2]), visceral fat mass (-402 g [95% CI, -539 to -266 g]), and total body fat mass (-7386 g [95% CI, -9239 to -5532 g]). At 12 months, significant differences in favor of VLCD plus exercise were seen for health-related QoL (0.06 units [95% CI, 0.01 to 0.11]), body weight (-5.4 kg [95% CI, -7.7 to -3.1 kg]), BMI (-1.9 kg/m2 [95% CI, -2.8 to -1.1 kg/m2]), overall hip improvement (pain, 7.1 units [95% CI, 0.4 to 13.8], and physical function, 6.7 units [95% CI, 0.4 to 13.0]). The VLCD-plus-exercise group lost on average 8.5% more body weight than the exercise-only group; 82% of VLCD-plus-exercise group lost more than 5% of their total body weight as compared to only 16% of the exercise-only group. Overall, this study suggests that, while the addition of a VLCD to a standard exercise regimen may not be effective in reducing hip pain severity, it may have positive effects on BMI, body composition, and quality of life among patients with hip osteoarthritis and overweight or obesity.

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: body fat percentagebody mass index (BMI)hip osteoarthritisjoint painosteoarthritisquality of lifevery low calorie dietweight loss
Previous Post

Canagliflozin may significantly improve glycemic control in children and adolescents with type 2 diabetes

Next Post

The Scan by 2 Minute Medicine®: Fibroids, Fatigue, Tainted Syrups, and Bariatric Barriers

RelatedReports

A balance scale with a syringe on one side and silhouettes of varying body sizes on the other, symbolizing weight management and GLP-1 medications.
2MM Trial Briefs

In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks

October 29, 2026
A detailed illustration of a human knee joint, with visual elements representing therapy options, including pills and a prosthetic component.
Chronic Disease

Low-dose radiotherapy may be effective as a short-term therapeutic option in knee osteoarthritis

October 8, 2026
Weight loss collage: a smiling bearded man in an open-collared shirt beside a coiled leather belt and a plate of salad greens
Endocrinology

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

August 31, 2026
Fatty liver disease may independently predict high-risk coronary disease
Cardiology

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

August 21, 2026
Next Post
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!

The Scan by 2 Minute Medicine®: Fibroids, Fatigue, Tainted Syrups, and Bariatric Barriers

Primary care collage: a smiling clinician in a white coat with a stethoscope before a network of teal dots, and a succulent

Kenya’s AI Consult reduces errors in 20000 clinical encounters

#VisualAbstract: Multidose Ondansetron after Emergency Department Visits Improves Outcomes in Children with Gastroenteritis

#VisualAbstract: Multidose Ondansetron after Emergency Department Visits Improves Outcomes in Children with Gastroenteritis

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind November 2, 2026
  • Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation
  • CDC reports increasing early-season influenza activity and at least 900 deaths nationwide
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.